Feb 22, 2017 at 15:32 | Source: Moneycontrol.com
Brawn Biotech Ltd has informed BSE about Outcome of Board Meeting held on February 22, 2017.
Feb 20, 2017 at 14:52 | Source: Moneycontrol.com
Marksans Pharma Ltd has informed BSE that the Company's plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa - 403 722 has had an inspection by UK MHRA from February 14, 2017 to February 17, 2017. The same has been completed without any critical observations.
Feb 20, 2017 at 14:40 | Source: Moneycontrol.com
Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on February 20, 2017.
Feb 20, 2017 at 13:25 | Source: Moneycontrol.com
Centrum is bearish on GlaxoSmithKline Pharma has recommended sell rating on the stock with a target price of Rs 1340 in its research report dated February 13, 2017.
Feb 20, 2017 at 08:26 | Source: CNBC-TV18
Idea Cellular | Axis Bank | Kotak Mahindra Bank | Hindustan Unilever | McNally Bharat | Havells | BPCL | GPT Infra | Mangalam Drugs and GSK Pharma are stocks, which are in the news today.
Feb 16, 2017 at 16:04 | Source: Moneycontrol.com
Ortin Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2017, has reviewed the status of demerger process requesting the independent Auditors and Merchant Bankers to expedite the completion of the reports and submit the same to the Company.
Feb 16, 2017 at 11:28 | Source: Moneycontrol.com
Edelweiss recommended hold rating on Glaxosmithkline with a target price of Rs 5773 in its research report dated February 13, 2017.
Feb 15, 2017 at 13:53 | Source: Moneycontrol.com
Shilpa Medicare Ltd has informed BSE that the board has approved the resignation of Mr. Venugopal Loya, Independent Director of the Company with effect from February 14, 2017.
Feb 15, 2017 at 11:25 | Source: Moneycontrol.com
Sanofi India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 27, 2017, to approve the audited accounts for the year ended December 31, 2016.
Feb 15, 2017 at 09:59 | Source: Moneycontrol.com
Jagsonpal Pharmaceuticals Ltd has informed BSE that Dr. Surinder Kumar Goyal, Director has resigned from Directorship of the Company w.e.f. February 14, 2017, his resignation has been approved by the Board of Directors in their meeting held on February 14, 2017. (Copy of resignation & resolution is enclosed).